Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): Study protocol for a randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Germans, Menno R ^a   Post, René ^a   Coert, Bert A ^a   Rinkel, Gabriël J E ^b   Vandertop, W Peter ^a   Verbaan, Dagmar ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antifibrinolytic agents; Early medical intervention; Functional outcome; Intracranial aneurysm; Neurosurgery; Rebleeding; Subarachnoid hemorrhage; Tranexamic acid

Indexed keywords

TRANEXAMIC ACID;

ADULT; ANEURYSM; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ANTIFIBRINOLYTIC AGENTS; CLINICAL PROTOCOLS; DISABILITY EVALUATION; DRUG ADMINISTRATION SCHEDULE; EARLY MEDICAL INTERVENTION; HUMANS; INFUSIONS, INTRAVENOUS; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RECURRENCE; RESEARCH DESIGN; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84877984570     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-143     Document Type: Article

References (21)

1. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007, 78:1365-1372. 10.1136/jnnp.2007.117655, 2095631, 17470467.
2. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013, 35:93-112. 10.1159/000346087, 23406828.
3. Wermer MJ, Kool H, Albrecht KW, Rinkel GJ. Subarachnoid hemorrhage treated with clipping: long-term effects on employment, relationships, personality, and mood. Neurosurgery 2007, 60:91-97.
4. Beck J, Raabe A, Szelenyi A, Berkefeld J, Gerlach R, Setzer M, Seifert V. Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke 2006, 37:2733-2737. 10.1161/01.STR.0000244762.51326.e7, 17008633.
5. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med 2006, 355:928-939. 10.1056/NEJMra052760, 16943405.
6. Guo LM, Zhou HY, Xu JW, Wang Y, Qiu YM, Jiang JY. Risk factors related to aneurysmal rebleeding. World Neurosurg 2011, 76:292-298. 10.1016/j.wneu.2011.03.025, 21986427.
7. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 2002, 97:771-778. 10.3171/jns.2002.97.4.0771, 12405362.
8. Starke RM, Kim GH, Fernandez A, Komotar RJ, Hickman ZL, Otten ML, Ducruet AF, Kellner CP, Hahn DK, Chwajol M, Mayer SA, Connolly ES. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke 2008, 39:2617-2621. 10.1161/STROKEAHA.107.506097, 18658042.
9. Starke RM, Connolly ES. Rebleeding after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011, 15:241-246. 10.1007/s12028-011-9581-0, 21761274.
10. Roos YB, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry 1997, 63:490-493. 10.1136/jnnp.63.4.490, 2169792, 9343129.
11. Laidlaw JD, Siu KH. Ultra-early surgery for aneurysmal subarachnoid hemorrhage: outcomes for a consecutive series of 391 patients not selected by grade or age. J Neurosurg 2002, 97:250-258. 10.3171/jns.2002.97.2.0250, 12186450.
12. Phillips TJ, Dowling RJ, Yan B, Laidlaw JD, Mitchell PJ. Does treatment of ruptured intracranial aneurysms within 24 hours improve clinical outcome?. Stroke 2011, 42:1936-1945. 10.1161/STROKEAHA.110.602888, 21680909.
13. Lamb JN, Crocker M, Tait MJ, Anthony BB, Papadopoulos MC. Delays in treating patients with good grade subarachnoid haemorrhage in London. Br J Neurosurg 2011, 25:243-248. 10.3109/02688697.2010.544787, 21545327.
14. Roos YB, Rinkel GJ, Vermeulen M, Algra A, Van GJ. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2003, 2:CD001245.
15. Gaberel T, Magheru C, Emery E, Derlon JM. Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis. Acta Neurochir (Wien) 2012, 154:1-9.
16. Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P, American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 2012, 43:1711-1737. 10.1161/STR.0b013e3182587839, 22556195, American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology.
17. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 1957, 2:200-215.
18. Janssen PM, Visser NA, DorhoutMees SM, Klijn CJ, Algra A, Rinkel GJ. Comparison of telephone and face-to-face assessment of the modified Rankin Scale. Cerebrovasc Dis 2010, 29:137-139. 10.1159/000262309, 19955737.
19. Ronne-Engstrom E, Enblad P, Lundstrom E. Outcome after spontaneous subarachnoid hemorrhage measured with the EQ-5D. Stroke 2011, 42:3284-3286. 10.1161/STROKEAHA.111.626283, 21998065.
20. Schulz KF, Grimes DA. Multiplicity in randomised trials II: subgroup and interim analyses. Lancet 2005, 365:1657-1661. 10.1016/S0140-6736(05)66516-6, 15885299.
21. Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, Lecky F, Brohi K, Willett K. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ 2012, 345:e5839. 10.1136/bmj.e5839, 3439642, 22968527.